awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33378228-3D486045-8ABB-461A-B26E-C0E022AF4401
Q33378228-3D486045-8ABB-461A-B26E-C0E022AF4401
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33378228-3D486045-8ABB-461A-B26E-C0E022AF4401
Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours
P2860
Q33378228-3D486045-8ABB-461A-B26E-C0E022AF4401
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33378228-3D486045-8ABB-461A-B26E-C0E022AF4401
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4205949f4d807cf9cde9c286a92f334b77a4ebfb
P2860
Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.